本院的住院患者抗炎保肝药合理应用调查分析  

Investigation and analysis of reasonable application of hospitalized patients with anti-inflammatory and liver protective medicine in our hospital

作　　者：沈斌[1] 方子正[1] 蒋利亚[2] 

机构地区：[1]嘉兴学院附属第一医院药剂科,浙江嘉兴314000 [2]嘉兴学院附属第一医院感染科,浙江嘉兴314000

出　　处：《中国临床药理学杂志》2015年第20期2055-2057,共3页The Chinese Journal of Clinical Pharmacology

基　　金：浙江省药学会医院药学专项科研基金资助项目(2014ZYY29)

摘　　要：目的了解本院住院患者抗炎保肝药临床合理应用情况。方法用横断面调查方法,调查2015年1月6日住院患者抗炎保肝药使用是否合理的情况。结果 2032例患者使用抗炎保肝药312例,使用率为15.35%,联合用药比率为41.35%;品种涉及5大类17个规格;抗炎保肝药使用例数前3位的科室分别是感染科、肝胆外科和肿瘤内科,使用率前3位的科室分别是感染科、结核科和皮肤科;不合理用药43例,其中无指征使用21例(48.84%),还存在品种选择、使用剂量、给药途径及疗程等问题。结论本院抗炎保肝药的使用存在不合理之处,医院应制定相应的标准,使临床用药趋向规范和合理。Objective To investigate the clinical application of anti - inflammatory and liver protective medicine in our hospital patients. Methods A cross - sectional survey method was used to survey the hos- pital patients use of anti - inflammatory and liver protective medicine in January 6, 2015. Results In 2032 patients the use of anti - inflammato- ry and liver protective medicine in 312 cases, the use rate of 15.35%, drug combination ratio of 41.35%. Varieties of 5 categories of 17 specifi- cations. The anti -inflammatory and liver protective medicine with the use of the number of the top 3 departments were Infectious Diseases, De- partment of Hepatobiliary Surgery and Department of Medical Oncology. The use rate of one of the top 3 departments were department of Infectious Disease, Department of Tuberculosis and Department of Dermatolo- gy. Unreasonable drug use were found in 43 cases, of which no indica- tions using 21 cases（48.84% ）, there were varieties selection, the use of dose, method and course of treatment. Conclusion Use is unreasonable in hospital patients with anti -inflammatory and liver protective medi- cine, the hospital should establish corresponding standard, norms and reasonable clinical application tendency.

关 键 词：抗炎保肝药 横断面调查 合理用药 分析 

分 类 号：R975.5[医药卫生—药品] R969.3[医药卫生—药学]